Epstein-Barr Virus and the Eye

References

• Nowalk A, Green M. Epstein-Barr virus. Microbiol Spectr. 2016;4(3). doi:10.1128/microbiolspec.DMIH2-0011-2015.
   PubMed Web of Science ®Google Scholar
• Cohen JI. Epstein-Bar virus infection. N Engl J Med. 2000;343(7):481–492. doi:10.1056/NEJM200008173430707.
   PubMed Web of Science ®Google Scholar
• Ayee R, Ofori MEO, Wright E, Quaye O. Epstein Barr virus associated lymphomas and epithelia cancers in humans. J Cancer. 2020;11(7):1737–1750. doi:10.7150/jca.37282.
   PubMed Web of Science ®Google Scholar
• Shannon-Lowe C, Rickinson A. The global landscape of EBV-associated tumors. Front Oncol. 2019;9:713. doi:10.3389/fonc.2019.00713.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Ko YH, Kim JE, et al., Hematopathology Study Group of the Korean Society of Pathologists. Epstein-Barr virus-associated lymphoproliferative disorders: review and update on 2016 WHO classification. J Pathol Transl Med. 2017;51(4):352–358. doi:10.4132/jptm.2017.03.15.
   PubMed Web of Science ®Google Scholar
• Farrall AL, Smith JR. Eye involvement in primary central nervous system lymphoma. Surv Ophthalmol. 2020 Feb 11:pii: S0039-6257(20)30025–4. doi:10.1016/j.survophthal.2020.02.001.
   PubMed Web of Science ®Google Scholar
• Pulido JS, Johnston PB, Nowakowski GS, Castellino A, Raja H. The diagnosis and treatment of primary vitreoretinal lymphoma: a review. Int J Retina Vitreous. 2018 May 7;4:18. doi:10.1186/s40942-018-0120-4.
   PubMedGoogle Scholar
• Fend F, Ferreri AJ, Coupland SE. How we diagnose and treat vitreoretinal lymphoma. Br J Haematol. 2016;173(5):680–692. doi:10.1111/bjh.14025.
   PubMed Web of Science ®Google Scholar
• Cohen JI, Iwatsuki K, Ko YH, et al. Epstein-Barr virus NK and T cell lymphoproliferative disease: report of a 2018 international meeting. Leuk Lymphoma. 2020;61(4):808–819. doi:10.1080/10428194.2019.1699080.
   PubMed Web of Science ®Google Scholar
• Arai A. Advances in the study of chronic active Epstein-Barr Virus infection: clinical features under the 2016 WHO classification and mechanisms of development. Front Pediatr. 2019;7:14. doi:10.3389/fped.2019.00014.
   PubMed Web of Science ®Google Scholar
• Kimura H, Cohen JI. Chronic active Epstein-Barr virus disease. Front Immunol. 2017;8:1867. doi:10.3389/fimmu.2017.01867.
   PubMed Web of Science ®Google Scholar
• Takahashi H, Takase H, Arai A, Mochizuki M, Ohno-Matsui K. Bilateral granulomatous panuveitis in two patients with T-cell type of chronic active Epstein-Barr virus infection. BMC Ophthalmol. 2019;19(1):83. doi:10.1186/s12886-019-1090-5.
   PubMedGoogle Scholar
• Isobe Y, Aritaka N, Setoguchi Y, et al. T/NK cell type chronic active Epstein-Barr virus disease in adults: an underlying condition for Epstein-Barr virus-associated T/NK-cell lymphoma. J Clin Pathol. 2012;65(3):278–282. doi:10.1136/jclinpath-2011-200523.
   PubMed Web of Science ®Google Scholar
• Grulich AE, Vajdic CM. The epidemiology of cancers in human immunodeficiency virus infection and after organ transplantation. Semin Oncol. 2015;42(2):247–257. doi:10.1053/j.seminoncol.2014.12.029.
   PubMed Web of Science ®Google Scholar
• Dierickx D, Habermann TM. Post-Transplantation Lymphoproliferative Disorders in Adults. N Engl J Med. 2018;378(6):549–562. doi:10.1056/NEJMra1702693.
   PubMed Web of Science ®Google Scholar
• Zierhut M, Rohrbach JM. Posttransplantation lymphoproliferative disorder. In: Zierhut M, Pavesio C, Ohno S, Oréfice F, Rao NA, eds.. Intraocular Inflammation. Springer-Verlag Berlin Heidelberg; 2016:1529–1534.
   Google Scholar
• Fugl A, Andersen CL. Epstein-Barr virus and its association with disease - a review of relevance to general practice. BMC Fam Pract. 2019;20(1):62. doi:10.1186/s12875-019-0954-3.
   PubMedGoogle Scholar
• AbuSalah MAH, Gan SH, Al-Hatamleh MAI, Irekeola AA, Shueb RH, Yean Yean C. Recent advances in diagnostic approaches for Epstein-Barr virus. Pathogens. 2020;9(3):pii: E226. doi:10.3390/pathogens9030226.
   PubMed Web of Science ®Google Scholar
• Kerr JR. Epstein-Barr virus (EBV) reactivation and therapeutic inhibitors. J Clin Pathol. 2019;72(10):651–658. doi:10.1136/jclinpath-2019-205822.
   PubMed Web of Science ®Google Scholar
• Andrei G, Trompet E, Snoeck R. Novel Therapeutics for Epstein⁻Barr Virus. Molecules. 2019;24(5):pii: E997. doi:10.3390/molecules24050997.
   Web of Science ®Google Scholar
• Draborg A, Izarzugaza JM, Houen G. How compelling are the data for Epstein-Barr virus being a trigger for systemic lupus and other autoimmune diseases? Curr Opin Rheumatol. 2016;28(4):398–404. doi:10.1097/BOR.0000000000000289.
   PubMed Web of Science ®Google Scholar
• Toussirot E, Roudier J. Epstein-Barr virus in autoimmune diseases. Best Pract Res Clin Rheumatol. 2008;22(5):883–896. doi:10.1016/j.berh.2008.09.007.
   PubMed Web of Science ®Google Scholar
• Usui M, Sakai J. Three cases of EB virus-associated uveitis. Int Ophthalmol. 1990;14(5–6):371–376. doi:10.1007/BF00163559.
   PubMed Web of Science ®Google Scholar
• Ongkosuwito JV, Van der Lelij A, Bruinenberg M, et al. Increased presence of Epstein-Barr virus DNA in ocular fluid samples from HIV negative immunocompromised patients with uveitis. Br J Ophthalmol. 1998;82(3):245–251. doi:10.1136/bjo.82.3.245.
   PubMed Web of Science ®Google Scholar
• Yamamoto S, Sugita S, Sugamoto Y, Shimizu N, Morio T, Mochizuki M. Quantitative PCR for the detection of genomic DNA of Epstein-Barr virus in ocular fluids of patients with uveitis. Jpn J Ophthalmol. 2008;52(6):463–467. doi:10.1007/s10384-008-0589-8.
   PubMed Web of Science ®Google Scholar
• Nahdi I, Abdelwahed RB, Boukoum H, et al. Herpesvirus detection and cytokine levels (IL-10, IL-6, and IFN-γ) in ocular fluid from Tunisian immunocompetent patients with uveitis. J Med Virol. 2013;85:2079–2086. doi:10.1002/jmv.23708.
   PubMed Web of Science ®Google Scholar
• Laaks D, Smit DP, Harvey J. Polymerase chain reaction to search for Herpes viruses in uveitic and healthy eyes: a South African perspective. Afr Health Sci. 2015;15(3):748–754. doi:10.4314/ahs.v15i3.7.
   PubMed Web of Science ®Google Scholar
• Groen-Hakan F, Van Der Eijk AA, Rothova A. The usefulness of aqueous fluid analysis for Epstein-Barr virus in patients with uveitis. Ocul Immunol Inflamm. 2020;28(1):126–132. doi:10.1080/09273948.2018.1543709.
   PubMed Web of Science ®Google Scholar
• Smit D, Meyer D, Maritz J, de Groot-mijnes JDF. Polymerase chain reaction and goldmann-witmer coefficient to examine the role of Epstein-Barr virus in uveitis. Ocul Immunol Inflamm. 2019;27(1):108–113. doi:10.1080/09273948.2017.1370653.
   PubMed Web of Science ®Google Scholar
• Murray PI, Fink C, Trivedi D. In Response to: smit D, Meyer D, Maritz J, et al. “Polymerase chain reaction and goldmann-witmer coefficient to examine the role of Epstein-Barr virus in uveitis”.. Ocul Immunol Inflamm. 2019;27(1):114–115. doi:10.1080/09273948.2017.1400075.
   PubMed Web of Science ®Google Scholar
• Smit DP, Meyer D, Maritz J, De Groot-Mijnes JDF. Authors Reply to Letter to the Editor- In Response to: “Smit D, Meyer D, Maritz J, et al. Polymerase chain reaction and goldmann-witmer coefficient to examine the role of Epstein-Barr virus in uveitis”. Ocul Immunol Inflamm. 2019;27(1):116. doi:10.1080/09273948.2017.1406957.
   PubMed Web of Science ®Google Scholar
• Keorochana N, Treesit I, Funarunart P. Characteristics and clinical outcomes of hypertensive anterior uveitis. Ocul Immunol Inflamm. 2020;28(4):537–547. doi:10.1080/09273948.2019.1587471.
   Web of Science ®Google Scholar
• Khieu C, Kongyai N, Pathanapitoon K, Van Der Eijk AA, Rothova A. Causes of hypertensive anterior uveitis in Thailand. Ocul Immunol Inflamm. 2020;28(4):558–564. doi:10.1080/09273948.2019.1678651.
   Web of Science ®Google Scholar
• Mashima A, Usui Y, Umazume K, Muramatsu D, Goto H. Successful treatment of necrotizing retinitis with Epstein-Barr virus-positive ocular fluid by intravitreal methotrexate injection. Ocul Immunol Inflamm. 2020;28(4):551–554. doi:10.1080/09273948.2019.1609047.
   Web of Science ®Google Scholar
• Chen Y, Xu H. Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis following cyclosporine for uveitis. Ocul Immunol Inflamm. 2020;28(4):548–550. doi:10.1080/09273948.2019.1606258.
   Web of Science ®Google Scholar
• Bustos-Mejia DA, Parra-Medina R, de-la-Torre A. Nodular necrotizing-scleritis associated with Epstein-Barr virus infection: a case report. Ocul Immunol Inflamm. 2020;28(4);555–557. doi:10.1080/09273948.2019.1611877.
   Web of Science ®Google Scholar
• Cunningham ET, Baglivo E. Fuchs heterochromic iridocyclitis–syndrome, disease, or both? Am J Ophthalmol. 2009 Oct;148(4):479–481. doi:10.1016/j.ajo.2009.06.007.
   PubMed Web of Science ®Google Scholar
• Zelefsky JR, Cunningham ET Jr. Evaluation and management of elevated IOP in patients with uveitis. American Academy of Ophthalmology, Focal Points 2010, Volume XXVIII, number 6 (Section 3 of 3).
   Google Scholar
• Cunningham ET, Zierhut M. Uveitic ocular hypertension and glaucoma. Ocul Immunol Inflamm. 2017 Dec;25(6):737–739. doi:10.1080/09273948.2017.1415077.
   PubMed Web of Science ®Google Scholar
• Cunningham ET Jr. Cytomegalovirus: ophthalmic perspectives on a pervasive pathogen. Expert Rev Ophthalmol. 2011;6(5):489–491. doi:10.1586/eop.11.50.
   Google Scholar
• Cunningham ET, Downes KM, Chee SP, Zierhut M. Cytomegalovirus retinitis and uveitis. Ocul Immunol Inflamm. 2015;23(5):359–361. doi:10.3109/09273948.2015.1090820.
   PubMed Web of Science ®Google Scholar
• Cunningham ET, Miserocchi E, Tugal-Tutkun I, Zierhut M. Varicella zoster virus-associated uveitis. Ocul Immunol Inflamm. 2018;26(2):167–170. doi:10.1080/09273948.2018.1444120.
   PubMed Web of Science ®Google Scholar
• Imai A, Takase H, Imadome KI, et al. Development of extranodal NK/T-cell lymphoma nasal type in cerebrum following Epstein-Barr virus-positive uveitis. Intern Med. 2017;56(11):1409–1414. doi:10.2169/internalmedicine.56.7573.
   PubMed Web of Science ®Google Scholar
• Takimoto-Shimomura T, Shimura Y, Nagata K, et al. Primary intraocular natural killer-cell lymphoma successfully treated using a multidisciplinary strategy. Ann Hematol. 2019;98(11):2617–2619. doi:10.1007/s00277-019-03807-7.
   PubMed Web of Science ®Google Scholar
• Abedi F, Borovik AM, Waring D, Hariz S, Francis IC. Primary intraocular natural killer/T-cell lymphoma unmasked with infective endophthalmitis after an intravitreal injection of bevacizumab. Clin Exp Ophthalmol. 2019;47(8):1088–1089. doi:10.1111/ceo.13561.
   PubMed Web of Science ®Google Scholar
• Maruyama K, Kunikata H, Sugita S, et al. First case of primary intraocular natural killer t-cell lymphoma. BMC Ophthalmol. 2015:169. doi:10.1186/s12886-015-0158-0.
   PubMed Web of Science ®Google Scholar
• Tagawa Y, Namba K, Ogasawara R, et al. A case of mature natural killer-cell neoplasm manifesting multiple choroidal lesions: primary intraocular natural killer-cell lymphoma. Case Rep Ophthalmol. 2015:380–384. doi:10.1159/000442018.
   PubMed Web of Science ®Google Scholar
• Bi YW, Wang SY, Qian J, Yuan YF, Li XQ, Zhu XZ. Ocular natural killer/T cell lymphoma: a clinicopathologic analysis. Zhonghua Yan Ke Za Zhi. 2019 May 11;55(5):374–380. doi:10.3760/cma.j..0412-4081.2019.05.012.
   PubMedGoogle Scholar
• Woog JJ, Kim YD, Yeatts RP, et al. Natural killer/T-cell lymphoma with ocular and adnexal involvement. Ophthalmology. 2006;113(1):140–147. doi:10.1016/j.ophtha.2005.09.036.
   PubMed Web of Science ®Google Scholar
• Coupland SE, Foss HD, Assaf C, et al. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases. Ophthalmology. 1999;106(11):2109–2120. doi:10.1016/S0161-6420(99)90492-X.
   PubMed Web of Science ®Google Scholar
• Lee EW, Mieler WF. Ocular findings in a patient with hemophagocytic syndrome. Arch Ophthalmol. 2006;124(11):1656–1658. doi:10.1001/archopht.124.11.1656.
   PubMedGoogle Scholar
• Li X, Ma Y, Tang J, Chen T, Ma X. A hemophagocytic lymphohistiocytosis patient that presented with unilateral panuveitis. Ocul Immunol Inflamm. 2017;25(2):275–277. doi:10.3109/09273948.2015.1107593.
   PubMed Web of Science ®Google Scholar
• Sebrow DB, Dhrami-Gavazi E, Horowitz JD, Yannuzzi LA. Purtscher retinopathy as a manifestation of hemophagocytic lymphohistiocytosis. Retin Cases Brief Rep. 2017;11(4):335–338. doi:10.1097/ICB.0000000000000360.
   PubMedGoogle Scholar
• Furukawa H, Hamada T, Nagaya K, Akiya S, Hamada T. A case of necrotizing scleritis associated with Epstein-Barr virus infection. Nippon Ganka Gakkai Zasshi. 1993;97:1337–1342.
   PubMedGoogle Scholar